FOLD Financials 07/21/2014 20:52:01
Amicus Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 363 18,411 21,434 922
Cost of Revenue - - - -
Gross Profit 363 18,411 21,434 922
Operating Expenses
Research and Development 41,944 50,273 50,856 39,042
Sales, General and Admin. 18,893 19,364 19,880 15,660
Non-Recurring Items 1,988 - - -
Other 1,719 1,705 1,585 2,058
Operating Income (64,181) (52,931) (50,887) (55,838)
Income From Continuing Operations
Add'l Income/Expense Items 1,082 990 2,994 23
Earnings Before Interest and Tax (63,099) (51,941) (47,893) (55,815)
Interest Expense 46 89 148 260
Earnings Before Tax (63,145) (52,030) (48,041) (56,075)
Income Tax (3,512) (3,245) (3,629) (1,139)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (59,633) (48,785) (44,412) (54,936)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (59,633) (48,785) (44,412) (54,936)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (59,633) (48,785) (44,412) (54,936)
Amicus Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 363 18,411 21,434 922
Cost of Revenue - - - -
Gross Profit 363 18,411 21,434 922
Operating Expenses
Research and Development 41,944 50,273 50,856 39,042
Sales, General and Admin. 18,893 19,364 19,880 15,660
Non-Recurring Items 1,988 - - -
Other 1,719 1,705 1,585 2,058
Operating Income (64,181) (52,931) (50,887) (55,838)
Income From Continuing Operations
Add'l Income/Expense Items 1,082 990 2,994 23
Earnings Before Interest and Tax (63,099) (51,941) (47,893) (55,815)
Interest Expense 46 89 148 260
Earnings Before Tax (63,145) (52,030) (48,041) (56,075)
Income Tax (3,512) (3,245) (3,629) (1,139)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (59,633) (48,785) (44,412) (54,936)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (59,633) (48,785) (44,412) (54,936)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (59,633) (48,785) (44,412) (54,936)
